» Articles » PMID: 21521384

Barriers and Facilitators to Cannabis Treatment

Overview
Specialty Psychiatry
Date 2011 Apr 28
PMID 21521384
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: INTRODUCTION AND AIMS. Despite its continued widespread use, relatively few individuals with cannabis use disorders present to treatment services. There is a dearth of research examining the reasons for this observed underutilisation of treatment. The aim of this paper is to examine barriers and facilitators to entry into cannabis treatment.

Design And Methods: Three surveys of regular cannabis users in treatment (n=100), in the community (n=100) and from a widespread Internet sample (n=294).

Results: Perceived barriers included: not being aware of treatment options; thinking treatment is unnecessary; not wanting to stop using cannabis; and wanting to avoid the stigma associated with accessing treatment. Perceived facilitators included: improving available information on treatment; keeping treatment specific to cannabis; offering additional services, such as telephone support; and simplifying treatment admission processes.

Discussion And Conclusions: Participant's perceptions differed significantly depending on their age, gender and treatment status. Participants in treatment typically reported barriers intrinsic to the individual while participants from the community reported barriers relating to the treatment available. Reported facilitators were more homogenous and most commonly related to availability of information.

Citing Articles

A mixed method study exploring similarities and differences in general and social services-specific barriers to treatment-seeking among individuals with a problematic use of alcohol, cannabis, or gambling.

Schettini G, Lindner P, Ekstrom V, Johansson M BMC Health Serv Res. 2024; 24(1):970.

PMID: 39174983 PMC: 11342637. DOI: 10.1186/s12913-024-11304-5.


Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies.

Cote J, Chicoine G, Vinette B, Auger P, Rouleau G, Fontaine G J Med Internet Res. 2024; 26:e55031.

PMID: 38630515 PMC: 11063887. DOI: 10.2196/55031.


Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.

Matson T, Williams E, Lapham G, Oliver M, Hallgren K, Bradley K Drug Alcohol Depend. 2023; 251:110946.

PMID: 37688980 PMC: 10655701. DOI: 10.1016/j.drugalcdep.2023.110946.


Assessing the Impact of Recreational Cannabis Legalization on Cannabis Use Disorder and Admissions to Treatment in the United States.

Aletraris L, Graves B, Ndungu J Curr Addict Rep. 2023; 10(2):198-209.

PMID: 37266190 PMC: 10088679. DOI: 10.1007/s40429-023-00470-x.


Motivators for Cannabis Use among Young Adults in Outpatient Psychiatric Care: A Qualitative Study.

Whiteley L, Haubrick K, Arnold T, Craker L, Olsen E, Hershkowitz D J Drug Issues. 2022; 51(3):590-604.

PMID: 36540131 PMC: 9762849. DOI: 10.1177/00220426211002125.